Beta Bionics Inc (NASDAQ: BBNX) Metrics That Matter Right Now

Beta Bionics Inc (NASDAQ:BBNX) shares, rose in value, with the stock price up by 1.83% to the previous day’s close as strong demand from buyers drove the stock to $11.14.

Actively observing the price movement in the last trading, the stock closed the session at $10.94, falling within a range of $10.63 and $11.23. Referring to stock’s 52-week performance, its high was $24.50, and the low was $8.89. On the whole, BBNX has fluctuated by -29.45% over the past month.

With the market capitalization of Beta Bionics Inc currently standing at about $482.92 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-Mar-24.

Projections by analysts suggest varying estimates for the company’s quarterly revenue. Analysts have estimated the company’s revenue for the quarter at 82.62M, with a low estimate of 15M and a high estimate of 18.12M. Wall Street analysts also predicted that the company’s y-o-y revenues would reach 16.15M.

The stock’s technical analysis shows that the price of BBNX currently trading nearly -5.39% and -31.03% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 40.06, while the 7-day volatility ratio is showing 9.13% which for the 30-day chart, stands at 11.76%. Furthermore, Beta Bionics Inc (BBNX)’s average true range (ATR) is 1.31.

Data on historical trading for Beta Bionics Inc (NASDAQ:BBNX) indicates that the trading volumes over the past 10 days have averaged 0.46 and over the past 3 months, they’ve averaged 622.82K. According to company’s latest data on outstanding shares, there are 43.35 million shares outstanding.

Nearly 20.36% of Beta Bionics Inc’s shares belong to company insiders and institutional investors own 38.06% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.14 million shares as on 2025-03-31, resulting in a short ratio of 4.84. According to the data, the short interest in Beta Bionics Inc (BBNX) stood at 817.00 of shares outstanding as of 2025-03-31; the number of short shares registered in 2025-02-28 reached 1.18 million. The stock has fallen by -52.86% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BBNX stock heading into the next quarter.

Stocks Register
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.